欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/V/0305/001
药品名称
EURICAN DAP
活性成分
canine adenovirus 0.0 CCID50
canine distemper virus 0.0 CCID50
canine parvovirus 0.0 CCID50
剂型
Lyophilisate and solvent for suspension for injection
上市许可持有人
MERIAL
参考成员国 - 产品名称
France (FR)
EURICAN DAP
互认成员国 - 产品名称
Germany (DE)
Eurican DAP
Denmark (DK)
Eurican DAP
Belgium (BE)
Eurican DAP
Netherlands (NL)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
Eurican DAP Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
Sweden (SE)
Norway (NO)
Finland (FI)
Poland (PL)
Latvia (LV)
Eurican DAP
Lithuania (LT)
Hungary (HU)
Eurican DHP vakcina A.U.V.
Bulgaria (BG)
Cyprus (CY)
Czechia (CZ)
Eurican DAP lyofilizát a rozpouštědlo pro injekční suspenzi
Romania (RO)
Slovakia (SK)
Slovenia (SI)
Malta (MT)
Croatia (HR)
许可日期
2016/02/24
最近更新日期
2024/04/24
药物ATC编码
QI07AD02 canine distemper virus + canine adenovirus + canine parvovirus
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Full dossier - art 12.3 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PAR
|
09073 EURICAN DAP_ PuAR fev2024
Date of last change:2024/02/05
Final Product Information
|
09073_eurican_dap_clean_20240201
Date of last change:2024/02/01
PAR
|
09073 EURICAN DAP- PuAR nov2016
Date of last change:2016/11/18
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase